查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1362881

药物释放型支架市场规模、份额和趋势分析报告：按涂层类型、用途、地区和细分市场预测，2023-2030年

Drug Eluting Stent Market Size, Share & Trends Analysis Report By Coating Type (Polymer-based Coatings (Non-biodegradable, Biodegradable)), Polymer-free Coatings, By Application, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

药物释放型支架市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球药物释放型支架市场规模预计将达到136.5亿美元，预测期内年复合成长率为8.4%。

高龄化以及心血管疾病（CVD）、复杂病变、糖尿病和肥胖等危险因子的日益患病将推动预测期内对药物释放型支架的需求。此外，支架设计的技术进步，例如改进的涂层和药物传输机制，正在提高这些设备的安全性和有效性，使它们对患者和医疗保健专业人员更具吸引力。

全球心血管疾病患病的增加正在刺激市场需求。根据2022年世界卫生联合会（WHF）报告，全球有超过5亿人持续罹患心血管疾病，2021年CVD将导致约2,050万人死亡，占全球整体死亡人数的近三分之一。冠状动脉疾病和周边动脉疾病疾病变得越来越常见，对 DES 等有效治疗方案的需求也迅速增加。这些具有药物涂层表面的支架为患者提供了微创解决方案，并有效防止血管再阻塞，从而改善患者的治疗效果。

药物释放型支架市场受到 COVID-19大流行的严重影响，该流行病扰乱了医疗设备供应链。由于所有主要製造商都专注于对抗 COVID-19，其他领域的收益受到了重大影响。冠状动脉支架市场的所有知名竞争都宣布，2020 年其介入性心臟病学产品组合（包括冠状动脉支架设备）的收益出现下降，这主要是由于 COVID-19 大流行的影响。

药物释放型支架市场报告亮点

  • 以涂料来看，聚合物基涂料领域在2022年占据了82.9%的主导收益占有率。这一市场份额可能是由于其在支架开发方面的广泛用途、经过验证的药物传输有效性以及适应各种治疗剂的多功能性，使其受到製造商和医疗相关人员的欢迎。此外，聚合物涂层技术的不断进步进一步巩固了我们的市场主导地位。
  • 药物释放型支架市场依用途分为冠状动脉疾病及周边动脉疾病，2022年前者占销售额的85.9%。这一增长是由全球冠状动脉疾病的高患病推动的，导致对药物释放型支架等有效治疗方案的大量需求。
  • 北美地区在 2022 年占据最大的收益占有率，达到 43.08%，预计将在整个预测期内主导市场。北美拥有发达且先进的医疗基础设施，包括医院。此外，该地区心血管疾病的患病不断上升，推动了对药物释放型支架等有效治疗方案的需求。

目录

第1章调查方法与范围

第2章执行摘要

第3章市场变数、趋势和范围

  • 市场区隔和范围
  • 市场体系预测
    • 母市场预测
    • 相关/附随市场预测
  • 市场趋势及展望
  • 市场动态
    • 心血管疾病患病增加
    • 支架设计的技术进步
    • 老年人口增加
  • 市场抑制因素分析
    • 高成本药物释放型支架
  • 2022 年普及与成长前景预测
  • 营商环境分析
    • SWOT 分析；要素因素（政治/法律、经济/技术）
    • 波特五力分析
  • COVID-19感染疾病的影响分析

第4章药物释放型支架市场：涂层类型細項分析

  • 药物释放型支架：2022 年和 2030 年市场占有率分析
  • 聚合物基涂料
  • 无聚合物涂层

第5章药物释放型支架市场：用途細項分析

  • 药物释放型支架：2022 年和 2030 年市场占有率分析
  • 冠状动脉疾病
  • 周边动脉疾病

第6章药物释放型支架市场：区域分析

  • 2022 年及 2030 年药物释放型支架市场占有率（按地区）
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第7章竞争形势

  • 公司分类
  • 策略规划
  • 2022 年公司市场占有率分析
  • 公司简介/名单
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Terumo Corporation
    • Medtronic
    • Biosensors International
    • Cook Medical
    • B. Braun
    • Biotronik
    • Lepu Medical Technology
Product Code: 978-1-68038-999-9

Drug Eluting Stent Market Growth & Trends:

The global drug eluting stent market size is expected to reach USD 13.65 billion by 2030, advancing at a CAGR of 8.4% during the forecast period, according to a new report by Grand View Research, Inc.. An aging population and the increasing prevalence of risk factors such as cardiovascular diseases (CVDs), complex lesions, diabetes, obesity, and others are expected to drive the demand for drug eluting stents over the forecast period. Additionally, ongoing technological advancements in stent design, including improvements in coatings and drug delivery mechanisms, are enhancing the safety and efficacy of these devices, making them more appealing to patients and healthcare professionals.

The increasing prevalence of cardiovascular diseases globally has fueled market demand. According to the World Health Federation report in 2022, over half a billion people globally continue to be affected by cardiovascular diseases, with CVD contributing to approximately 20.5 million deaths in 2021, accounting for nearly a third of all deaths globally. Conditions like coronary artery disease and peripheral artery disease are becoming increasingly common, leading to a surge in demand for effective treatment options such as DES. These stents, equipped with drug-coated surfaces, offer patients a minimally invasive solution, effectively preventing restenosis and leading to improved patient outcomes.

The market for drug eluting stents was significantly impacted by the COVID-19 pandemic, with disruptions in the supply chain of medical devices. Since the focus of all major manufacturers was to fight the COVID-19 battle, the revenues of other segments were highly impacted. All notable competitors in the market for coronary stents announced a decline in revenue for their interventional cardiology portfolios, which include coronary stent devices in 2020, owing mostly to the impact of the COVID-19 pandemic.

Drug Eluting Stent Market Report Highlights:

  • Based on coating, the polymer-based coating segment held the dominant revenue share of 82.9% in 2022. This share can be attributed to its extensive usage in stent development, proven efficacy in drug delivery, and versatility in accommodating various therapeutic agents, making it a preferred choice for manufacturers and healthcare professionals alike. Additionally, continuous advancements in polymer-based coating technology have further solidified its leading position in the market
  • Based on application, the market for drug eluting stents has been categorized into coronary artery disease and peripheral artery disease, with the former accounting for 85.9% of the revenue share in 2022. The growth can be attributed to the high prevalence of coronary artery disease globally, leading to a substantial demand for effective treatment options such as drug eluting stents
  • The North American region held the largest revenue share of 43.08% in 2022 and is expected to dominate the market through the forecast period. North America has a well-developed and advanced healthcare infrastructure, including hospitals. Additionally, the increasing prevalence of cardiovascular diseases in the region has driven the demand for effective treatment options such as drug eluting stents

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Information Procurement
  • 1.2. Information Or Data Analysis
  • 1.3. Market Scope & Segment Definition
  • 1.4. Market Model
    • 1.4.1. Market Study, By Company Market Share
    • 1.4.2. Regional Analysis

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
    • 3.4.1. Increasing Prevalence of Cardiovascular Diseases
    • 3.4.2. Technological Advancements in Stent Design
    • 3.4.3. Growing Geriatric Population
  • 3.5. Market Restraint Analysis
    • 3.5.1. High Cost of Drug Eluting Stents
  • 3.6. Penetration And Growth Prospect Mapping 2022
  • 3.7. Business Environment Analysis
    • 3.7.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
    • 3.7.2. Porter's Five Forces Analysis
  • 3.8. COVID-19 Impact Analysis

Chapter 4. Drug Eluting Stent Market: Coating Type Segment Analysis

  • 4.1. Drug Eluting Stent: Market Share Analysis, 2022 & 2030
  • 4.2. Polymer-Based Coating
    • 4.2.1. Polymer-Based Coating Market, 2018 - 2030 (USD Billion)
      • 4.2.1.1. Non-Biodegradable Polymers
      • 4.2.1.2. Biodegradable Polymers
  • 4.3. Polymer-free Coating
    • 4.3.1. Polymer-Free Coating Market, 2018 - 2030 (USD Billion)
      • 4.3.1.1. Micro Porous Surface
      • 4.3.1.2. Micro Structured Surface
      • 4.3.1.3. Slotted Tubular Surface
      • 4.3.1.4. Nanoporous Surface

Chapter 5. Drug Eluting Stent Market: Application Segment Analysis

  • 5.1. Drug Eluting Stent: Market Share Analysis, 2022 & 2030
  • 5.2. Coronary Artery Disease
    • 5.2.1. Coronary Artery Disease Market, 2018 - 2030 (USD Billion)
  • 5.3. Peripheral Artery Disease
    • 5.3.1. Peripheral Artery Disease Market, 2018 - 2030 (USD Billion)

Chapter 6. Drug Eluting Stent Market: Regional Analysis

  • 6.1. Drug Eluting Stent Market Share, By Region, 2022 & 2030
  • 6.2. North America
    • 6.2.1. North Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.2.2. U.S.
      • 6.2.2.1. Key Country Dynamics
      • 6.2.2.2. Competitive Scenario
      • 6.2.2.3. Regulatory Framework
      • 6.2.2.4. U.S. Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.2.3. Canada
      • 6.2.3.1. Key Country Dynamics
      • 6.2.3.2. Competitive Scenario
      • 6.2.3.3. Regulatory Framework
      • 6.2.3.4. Canada Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
  • 6.3. Europe
    • 6.3.1. Europe Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.3.2. UK
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Competitive Scenario
      • 6.3.2.3. Regulatory Framework
      • 6.3.2.4. UK Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.3.3. Germany
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. Regulatory Framework
      • 6.3.3.4. Germany Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.3.4. France
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Competitive Scenario
      • 6.3.4.3. Regulatory Framework
      • 6.3.4.4. France Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.3.5. Italy
      • 6.3.5.1. Key Country Dynamics
      • 6.3.5.2. Competitive Scenario
      • 6.3.5.3. Regulatory Framework
      • 6.3.5.4. Italy Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.3.6. Spain
      • 6.3.6.1. Key Country Dynamics
      • 6.3.6.2. Competitive Scenario
      • 6.3.6.3. Regulatory Framework
      • 6.3.6.4. Spain Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.3.7. Denmark
      • 6.3.7.1. Key Country Dynamics
      • 6.3.7.2. Competitive Scenario
      • 6.3.7.3. Regulatory Framework
      • 6.3.7.4. Denmark Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.3.8. Sweden
      • 6.3.8.1. Key Country Dynamics
      • 6.3.8.2. Competitive Scenario
      • 6.3.8.3. Regulatory Framework
      • 6.3.8.4. Sweden Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.3.9. Norway
      • 6.3.9.1. Key Country Dynamics
      • 6.3.9.2. Competitive Scenario
      • 6.3.9.3. Regulatory Framework
      • 6.3.9.4. Norway Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.4.2. Japan
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Japan Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.4.3. China
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. China Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.4.4. India
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. India Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.4.5. Australia
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Competitive Scenario
      • 6.4.5.3. Regulatory Framework
      • 6.4.5.4. Australia Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.4.6. Thailand
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Competitive Scenario
      • 6.4.6.3. Regulatory Framework
      • 6.4.6.4. Thailand Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.4.7. South Korea
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Competitive Scenario
      • 6.4.7.3. Regulatory Framework
      • 6.4.7.4. South Korea Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
  • 6.5. Latin America
    • 6.5.1. Latin America Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.5.2. Brazil
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Brazil Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.5.3. Mexico
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Mexico Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.5.4. Argentina
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Argentina Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
  • 6.6. MEA
    • 6.6.1. MEA Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.6.2. South Africa
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. South Africa Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Saudi Arabia Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.6.4. UAE
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. UAE Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.6.5. Kuwait
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Kuwait Drug Eluting Stent Market, 2018 - 2030 (USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Share Analysis, 2022
  • 7.4. Company Profiles/Listing
    • 7.4.1. Abbott Laboratories
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Boston Scientific Corporation
      • 7.4.2.1. Overview
      • 7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Terumo Corporation
      • 7.4.3.1. Overview
      • 7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Medtronic
      • 7.4.4.1. Overview
      • 7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. Biosensors International
      • 7.4.5.1. Overview
      • 7.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. Cook Medical
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. B. Braun
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. Biotronik
      • 7.4.8.1. Overview
      • 7.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. Lepu Medical Technology
      • 7.4.9.1. Overview
      • 7.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 List of Secondary Sources

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Drug eluting stent market segmentation
  • Fig. 8 Market snapshot, 2022
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market driver relevance analysis (Current & future impact)
  • Fig. 11 Market restraint relevance analysis (Current & future impact)
  • Fig. 12 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 13 Porter's Five Forces analysis
  • Fig. 14 Market penetration & growth prospect mapping, 2022
  • Fig. 15 Global drug eluting stent market: Coating type movement analysis
  • Fig. 16 Global drug eluting stent market, for polymer-based coating, 2018 - 2030 (USD Billion)
  • Fig. 17 Global drug eluting stent market, for polymer-free coating, 2018 - 2030 (USD Billion)
  • Fig. 18 Global drug eluting stent market: Application movement analysis
  • Fig. 19 Global drug eluting stent market, for coronary artery disease, 2018 - 2030 (USD Billion)
  • Fig. 20 Global drug eluting stent market, for peripheral artery disease, 2018 - 2030 (USD Billion)
  • Fig. 21 Regional marketplace: Key takeaways
  • Fig. 22 Regional outlook, 2022 & 2030
  • Fig. 23 Global drug eluting stent market: Regional movement analysis
  • Fig. 24 North America drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 25 U.S. drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 26 Canada drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 27 Europe drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 28 Germany drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 29 UK drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 30 France drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 31 Italy drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 32 Spain drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 33 Denmark drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 34 Sweden drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 35 Norway drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 36 Asia Pacific drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 37 Japan drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 38 China drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 39 India drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 40 Australia drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 41 South Korea drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 42 Thailand drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 43 Latin America drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 44 Brazil drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 45 Mexico drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 46 Argentina drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 47 Middle East and Africa drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 48 South Africa drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 49 Saudi Arabia drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 50 UAE drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 51 Kuwait drug eluting stent market, 2018 - 2030 (USD Billion)